MGRM (Monogram Orthopedics) Company Net Assets

MGRM (monogramorthopedics.com) - company brandmark

Monogram Technologies (MGRM) is minimizing production disruption risks by expanding its list of titanium and electronics suppliers. Profit growth is expected following FDA approval of robotic systems for bone surgery, which is reflected in the price action, where the indicator stands at 0.01. Monogram Technologies (MGRM) generates revenue through the sale of unique surgical robots with patient-specific customization, enabling the company to implement premium pricing and mandatory service contracts.

MGRM Monogram Orthopedics Book Capitalization (02/21/2024 - 10/18/2025)

Monogram Orthopedics (MGRM) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Performance Chart Monogram Orthopedics Inc.|MGRM - Price Target Chart
- market capitalization data:
Market Valuation Monogram Technologies Inc.|MGRM - Total Company Value
- book capitalization data:
Accounting Value per Share Monogram Orthopedics|MGRM - Book Capitalization|Market-to-Book Ratio monogramorthopedics.com|MGRM - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Monogram Technologies|MGRM - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Monogram Technologies Inc.|MGRM - Company Aggregate Debts|Debt to Book Value Monogram Technologies Inc.
Fundamental valuation:MGRM - Monogram Orthopedics Inc.
Mass-produced product of Monogram Technologies Inc

Assessing the asset quality of Monogram Technologies (MGRM) requires an analysis of its equity structure. The dynamics of the company's net assets reflect the difference between total liabilities and the value of all resources. This metric measures the real value of the business, net of debt, and reacts to borrowing costs. For this AI systems developer, such capital provides protection for its patent moat. A high level of this indicator guarantees stability when scaling sales of high-margin implants.

Competitor analysis for Monogram Technologies

ISRG: Accounting Value of Company|DHR (Danaher Corp.) - Company Book Value|BDX (bd.com) - Company Net Assets|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value STAAR Surgical (STAA)|Company Book Value Chromadex Corp NAGE|Company Net Assets ZimVie Dental|Accounting Value of Company AngioDynamics Inc. ANGO|Book Capitalization CERS (Cerus Corporation)|TKNO: Book Valuation of Business|Company Book Value sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)